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Abstract
Introduction. The extremely-low frequency electromagnetic field (ELFEMF) has been proposed for use in can-
cer therapy since it was found that magnetic waves interfere with many biological processes. Gold nanoparticles 
(Au-NPs) have been widely used for drug delivery during cancer in vitro studies due to their low cytotoxity and 
high biocompatibility. The electroporation of cancer cells in a presence of Au-NPs (EP Au-NPs) can induce cell 
apoptosis, alterations of cell cycle profile and morphological changes. The impact of ELFEMF and EP Au-NPs 
on morphology, cell cycle and activation of apoptosis-associated genes on Hep-2 laryngeal cancer cell line has 
not been studied yet. 
Materials and methods. ELFEMF on Hep-2 cells were carried out using four different conditions: 25/50 mT 
at 15/30 min, while Au-NPs were used as direct contact (DC) or with electroporation (EP, 10 pulses at 200V, 
equal time intervals of 4 sec). MTT assay was used to check the toxicity of DC Au-NPs. Expression of CASP3, 
P53, BAX and BCL2 genes was quantified using qPCR. Cell cycle was analyzed by flow cytometry. Hematoxylin 
and eosin (HE) staining was used to observe cell morphology.
Results. Calculated IC50 of DC Au-NPs 24.36 µM (4.79 µg/ml) and such concentration was used for further 
DC and EP AuNPs experiments. The up-regulation of pro-apoptotic genes (CASP3, P53, BAX) and decreased 
expression of BCL2, respectively, was observed for all analyzed conditions with the highest differences for EP 
AuNPs and ELFEMF 50 mT/30 min in comparison to control cells. The highest content of cells arrested in G2/M 
phase was observed in ELFEMF-treated cells for 30 min both at 25 or 50 mT, while the cells treated with EP 
AuNPs or ELFEMF 50 mT/15 min showed highest ratios of apoptotic cells. HE staining of electroporated cells 
and cells exposed to ELFEMF’s low and higher frequencies for different times showed nuclear pleomorphic 
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cells. Numerous apoptotic bodies were observed in the irregular cell membrane of neoplastic and necrotic cells 
with mixed euchromatin and heterochromatin. 
Conclusions. Our observations indicate that treatment of Hep-2 laryngeal cancer cells with ELFEMF for 30 min 
at 25–50 mT and EP Au-NPs can cause cell damage inducing apoptosis and cell cycle arrest. (Folia Histochemica 
et Cytobiologica 2019, Vol. 57, No. 4, 159–167)
Key words: gold nanoparticles; electroporation; extremely-low frequency electromagnetic field; Hep-2 cells; 
apoptosis; qPCR
Introduction
Laryngeal cancer most often refers to squamous cell 
carcinoma of the larynx. Other malignant tumors of 
the larynx (e.g., sarcoma, lymphoma, neuroendocrine 
tumors) are extremely rare in comparison. This dis-
ease consists of malignant tumors of mucosal origin 
that originate from the supra-glottis, glottis, and 
sub-glottis. Electromagnetic fields (EMFs) have been 
employed as useful tools in medical diagnosis. Recent-
ly, the use of EMFs has been expanded for therapeutic 
purposes because their interactions with living matter 
produce effects that initiate, accelerate or inhibit 
biological processes. Frequencies below 300 Hz 
are known as extremely low-frequency electromagnet-
ic fields (ELFEMFs) which do not break molecular 
bonds due to low energy; therefore not causing direct 
DNA damage. Additionally, ELFEMFs are non-in-
vasive and non-ionizing and even have non-thermal 
effects on cells and tissues. These properties have 
led to studies on the influence of ELFEMF on the 
development of various diseases, including cancer. 
While some researchers associate ELFEMF exposure 
with carcinogenesis [1, 2], other studies on experi-
mental models and human cancers have shown that 
ELFEMF does not increase the risk of development of 
several tumor types, including liver cancer [3–5]. The 
ELFEMF treatment with tumor-specific frequencies 
is feasible and well-tolerated and may show positive 
biological efficacy in patients with advanced tumors 
[3–5]. Moreover, the exposure of female C3H/HeJ 
mice bearing human mammary adenocarcinoma to 
a frequency of 120 Hz at intensities of 4 and 5 mT 
resulted in a significant reduction in the growth of 
the tumors, which is a phenomenon associated with 
inhibition of angiogenesis [6]. Also, the exposure of 
female athymic nude mice with human breast cancer 
xenografts to a frequency of 120 Hz with an intensity 
of 15 mT, either alone or in combination with gamma 
radiation, resulted in decreased growth or reduced 
vascularization of the tumors [7]. Similarly, the effect 
of 50 Hz at 0.5 µT and 0.5 mT on the development of 
chemically induced foci in rat livers showed a slight 
inhibition of foci formation [8]. Further studies on 
ELFEMFs’ impact on cancer cells are demanded 
since the current observations are insufficient as 
a proof of ELFEMF inhibition of carcinogenesis. The 
anticancer activity of gold nanoparticles (Au-NPs) 
has been studied against Dalton’s lymphoma ascites 
(DLA) cell lines, human epithelial type 2 (Hep-2) 
cell lines and human leukemic monocyte lymphoma 
respectively [9, 10]. The anticancer effect of silver and 
gold nanoparticles against HepG-2 and lung cancer 
(A549) cell lines was performed [11, 12]. The results 
showed a good cytotoxic activity against the tested 
cancer cell lines. The concentration of Au-NPs plays 
an important role in their anticancer activity. Au-NPs 
showed expected effects against A549 cells in wide 
spectrum of concentrations: 100, l g, by 50 µg, 25 µg 
and 1 µg. The lowest inhibitory effect on cells was 
observed for the concentration of 10 µg. The cytotoxic 
effect of Au-NPs is the result of active physicochem-
ical interaction of gold atoms with the functional 
groups of intracellular proteins, as well as with the 
nitrogen bases and phosphate groups in DNA. So, 
the aim of this study was to use electroporation in 
a presence of Au-NPs and ELFEMF effect on laryngeal 
carcinoma cell line (Hep-2) to evaluate genetic alter-
ation under the effect of both electroporated Au-NPs 
and ELFEMF at different time and frequencies and 
related pathological changes [7]. 
Materials and methods
Cell culture. Laryngeal adenocarcinoma cell line (Hep-2, 
ATCC: CCL-23) was kindly supplied from the Holding 
company, Tissue Culture Department, for production of 
vaccines, sera, and drugs (VACSERA, Giza, Egypt). Cells 
were maintained in MEM-E medium supplemented with 
10% fetal bovine serum (GIBCO, Thermo Fisher Scientific, 
Waltham, MA, USA) in a humidified atmosphere of 5% 
CO2 at 37°C (Jouan SA, Saint-herblain, Pays de la Loire, 
France). Cells were maintained according to manufacturing 
protocol where the growth medium was decanted and cells 
were washed with phosphate buffer saline (Adwia Pharma-
ceuticals, El Sharkeya, Egypt). Cells were treated with 0.25% 
trypsin enzyme and 0.05% (v/v) EDTA (GIBCO) for 5 min 
at 37°C. Detached cells were splatted according to need. 
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Cell Viability and Au-NPs IC50 evaluation (MTT Assay). 
Cytotoxicity was conducted according to the previous work 
[13] where human laryngeal cancer cells were propagated 
in 75 cm2 cell culture (TPP-Swiss) as previously mentioned 
according to the previously reported work [13]. Cells were 
plated at a concentration of 2 × 105 cell/ml in 96-well cell 
culture plates and incubated at 37°C for 24 h to achieve 
confluence. The growth medium was decanted and fresh 
medium containing 2 fold serially diluted Au-NPs dispensed 
to pre-cultured plate. 24 hrs later, dead cells were washed out 
using phosphate buffer saline (PBS, pH = 7.2 ± 0.2 (Adwia) 
and 50 µl of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphen-
yltetrazolium bromide) stock solution (0.5 mg/ml) were add-
ed per well. After 4 h incubation period at 37°C, the superna-
tant was discarded and the formazan precipitate was solubi-
lized by addition of 50 µl/well of dimethyl sulfoxide (DMSO). 
Plates were incubated in the dark for 30 min at 37°C and 
absorbance was determined at a wavelength of 570 nm 
using microplate reader (ELx-800, Bio-Tek Instruments, 
Inc, Winooski, VT, USA). The cell viability percentage was 
calculated using the following formula: Viability percentage 
(%) = Mean OD of test dilution × 100/Mean OD of control 
wells. The IC50 value was determined using GraphPad Prism 
software (v.6, GraphPad Software, La Jolla, CA, USA). For 
cell cycle and apoptotic profile, Hep-2 cells were pre-cul-
tured in 25 cm2 surface area (SA) cell culture flasks, treated 
with the IC50 of Au-NPs in MEM-E medium post decanting 
the growth medium. 24 h later the affected cells were col-
lected and divided for cell cycle and genetic analysis, the 
cells were harvested and fixed gently with 70% (v/v) ethanol 
in PBS, maintained at a temperature of 4°C overnight, and 
re-suspended in PBS containing 40 µg/ml PI (propidium 
iodide), 0.1 mg/ml RNase and 0.1% (v/v) Triton X-100 in 
a dark room. After 30 min at 37°C, the cells were analyzed 
using a flow cytometer (Becton-Dickinson, San Jose, CA, 
USA) equipped with an argon ion laser at a wavelength of 
488 nm. The cell cycle and sub-G1 group were determined 
and analyzed, as described previously. 
Electroporation of laryngeal cancer cells. Hep-2 cells were 
seeded in 75 cm2 cell culture flasks and incubated at 37°C 
(5% CO2) until attachment. Cells were trypsinized and 
pelleted using cold centrifugation (Jouan-Ki21, ParisTech, 
France), the supernatant was decanted and Au-NPs (0.5 µM/ 
/mL) were added to 0.5 mL of Hep-2 cells and mixed well. 
Cells – Au-NPs (at the final concentration calculated 
as IC50 for DC AuNPs) mix was placed in the sterile 
MicroPulser electroporation cuvette (Biorad, Hercules, 
CA, USA). Ten pulses were made at 200V and applied to 
the cells at equal time intervals of 4 s. Negative control was 
considered.
Extremely-low frequency electromagnetic field treatment 
(ELFEMF). Four sterile test tubes of detached Hep-2 cancer 
cell line (2 × 106 cell/ml/tube) were categorized, where two 
of the tubes were subjected to the electromagnetic field as 
25 mT for 15 and 30 mins in a cooling atmosphere. The other 
two tubes were exposed to the electromagnetic field at 50 mT 
for the same time intervals. The apparatus (Medical Physics, 
Swiss Tropical and Public Health Institute, Basel, Switzer-
land) was adjusted for each magnetic field frequency using 
a teslameter set for justification of a magnetic field. The test 
tubes were kept inside the center of the coil producing EMF. 
The test tubes were tested for apoptotic profile regarding the 
pro-and anti-apoptotic genes (P53, Bd-2, Bax, caspase-3), 
cell cycle and histological profile were considered. 
Hematoxylin and eosin staining of Hep-2 cells. Fifty mi-
croliters of Au-NPs electroporated and ELFEMF exposed 
cells were dispensed on clean slides (3 for each treatment). 
Slides were air-dried, methanol fixed and rehydrated in 
descending concentrations of alcohol (100%, 90%, 75% 
and 50%). Slides were washed in distilled water for 5 min. 
The slides were immersed in filtered hematoxylin (HE) stain 
for 3 min and washed with distilled water twice. Slides were 
immersed in filtered eosin stain for 5 seconds and washed 
with distilled water. Dried slides were immersed in xylene, 
mounted with Canada balsam then coverslips were placed 
and left to dry. Ten microscopic fields of each slide were 
photomicrographed using the power of 400×. This was done 
using a digital camera (Canon, Tokyo, Japan), which was 
mounted on a light microscope. Images were transferred to 
the computer system for analysis. Field selection was based 
on the presence of the highest number of apoptotic cells. 
The photomicrographs were qualitatively evaluated for the 
presence of morphological criteria of apoptosis. 
Expression of apoptosis-related genes. Total RNA was 
extracted from control, ELFEMF (25/50 mT for 15 and 
30 min), 1 mM Au-NPs direct contact and electroporated 
exposed cells, respectively using RNeasy Mini Kit (Qiagen, 
Germantown, MD, USA) according to manufacturer’s 
instructions. The concentration of extracted RNA was eval-
uated using a Beckman dual spectrophotometer (Beckman 
Instruments, Ramsey, MN, USA). The expression level of 
apoptosis-related genes; P53 (F: 5’-TCAGATCCTAGC 
GTCGAGCCC-3’ & R: 5’-GGGTGTGGAATCAACCCA-
CAG-3’), BAX (F: 5’-ATGGACGGGTCCGGGGAGCA-3’ 
& R: 5’-CCCAGTTGAAGTTGCCGTCA-3’) and 
BCL2 (F: 5’-GTGAACTGGGGGAGGATTGT-3’& R: 
5’-GGAGAAATCAAACAGAGGCC-3’) CASP3 (F 5- 
CTCGGTCTGGTACAGATGTCGA-3’ & R: (5- CAT-
GGCTCAGAAGCACACAAAC-3) and housekeeping 
gene; ACTB (F 5’- AGCGAGCATCCCCCAAAGTT-3’& 
R: 5’-GGGCACGAAGGCTCATCATT-3) were deter-
mined using real-time PCR. 10 ng of the extracted total 
RNA from each sample was used for cDNA synthesis using 
high capacity cDNA reverse transcriptase kit (Applied 
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Biosystems-Thermo Fischer Scientific, USA). The obtained 
cDNA was subsequently amplified using Sybr Green I PCR 
master kit (Thermo Fisher Scientific Inc., Lithuania) using 
Step One apparatus (Applied Biosystems), as follows: 10 min 
at 95°C for enzyme activation followed by 40 cycles of 15 s 
at 95°C, 20 s at 55°C and 30 s at 72°C for the amplification 
step. Changes in the expression of each target gene were 
normalized relative to the mean critical threshold (CT) 
values of b-actin as housekeeping gene by the DCT method. 
Cell cycle analysis. Cell cycle distribution was examined by 
measuring the DNA content of nuclei labeled with propid-
ium iodide (PI). Au-NPs electroporated and ELFEMF 
treated Hep-2 cells were pelleted by cold centrifugation 
(Jouan Ki-21-France), washed with 1 ml of cold PBS, 
centrifuged, and fixed in 70% cold ethanol at +4°C for 24 
hrs. Subsequently, cells were washed twice and treated with 
RNase A (20 mg/ml) and PI (20 mg/ml), FITC conjugated 
Annexin-V according to the protocol described by the man-
ufacturer for 30 min at 37°C in the dark. Finally, cell cycle 
distribution analysis was performed using flow cytometry 
and the percentages of cells at G1, S and G2/M phases 
were calculated by flow cytometry (Becton-Dickinson).
Statistical analysis. All experiments were carried out three 
independent times. Results were statistically analyzed using 
GraphPad Prism v. 6.07 (GraphPad Software, San Diego, 
CA, USA) with the following tests: t-test between 2 sub-
groups, one-way analysis of variance (ANOVA) between 
more than two subgroups, regression analysis and Spear-
man’s correlation test. All results were presented as mean 
± SD. The difference was considered statistically significant 
at P < 0.05. 
Results
The toxicity test of Au-NPs was performed on Hep-2 
cells and the results were shown in Figure 1. Based on 
that, the calculated IC50 concentration was 24.36 µM/
ml (4.79 µg/ml). Such concentration of Au-NPs was 
used in further experiments with electroporation (EP 
Au-NPs) or by direct contact between Au-NPs and 
Hep-2 cells (DC Au-NPs). The influence of ELFEMF 
on Hep-2 cells was carried out using four different 
magnetic induction/time values: 25 mT/15 min, 
25 mT/30 min, 50 mT/15 min and 50 mT/30 min. 
The expression profile of three pro-apoptotic genes 
(CASP3, P53, BAX) and one anti-apoptotic gene 
(BCL2) of Au-NPs and ELFEMF treated cells showed 
statistically different ratios (Fig. 2). We found the 
highest expression of CASP3, P53 and BAX genes 
in EP Au-NPs and ELFEMFs cells at 50 mT/30 min 
(Fig. 2 A, B, C). Moreover, the tendency of increas-
ing expression of pro-apoptotic genes was observed 
in higher magnetic field/time values (P > 0.05, data 
not shown). We found that the electroporation with 
Au-NPs influenced the expression of CASP3, P53 and 
BAX the similar way vs. direct contact with Au-NPs 
as increasing ELFEMF values. Regarding the BCL2 
gene, we did not observe the association between 
ELFEMF values and BCL2 expression rate (except 
for the 25/15 vs. 50/30 mT/min values). Again, we 
found that EP Au-NPs-treated Hep-2 cells presented 
the lowest ratio of BCL2 expression. The presented 
results showed that the electroporation with Au-NPs 
(at the concentration of 24.36 µM) as well as the 
usage of ELFEMF at 50 mT/30 min values activated 
the expression of analyzed pro-apoptotic genes and 
deactivated the expression of anti-apoptotic BCL2 
gene at the highest values of tested conditions. 
Next, we checked the influence of Au-NPs and 
ELFEMF on the cell cycle of Hep-2 cells (Fig. 3). The 
significant G2/M phase arrest was observed for cells 
treated with all ELFEMFs (except for 50 mT/15 min) 
values (Fig. 3C). It seems that the G2/M arrest was 
associated with prolonged time of exposure rather 
than higher dose of electromagnetic field. The similar 
pattern of ELFEMF impact was found in apoptotic 
cell distribution (Fig. 3D). Although the distribution 
of apoptotic cells in EP Au-NPs treated cells was high-
er than in control cells (Fig. 3D), we did not observed 
cellular arrest in any of analyzed cell cycle phases 
when cells were treated with gold nanoparticles. 
The microscopic observation of ELFEMF exposed 
and Au-NPs electroporated cells showed morphologi-
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Figure 1. Evaluation of cytotoxicity of gold nanoparticles on 
Hep-2 cells using MTT assay. The calculated IC50 was 24.26 
µM using Graphpad Prism software. The values obtained 
from three separate experiments are shown (mean ± SD) and 
the nonlinear regression curve was added to plot, R2 = 0.972.
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cal differences in comparison to control cells (Fig. 4). 
Hematoxylin and eosin staining of control, Hep-2 
cells, showed regular cellular pleomorphic and nu-
clear pleomorphic cells (Fig. 4A), Au-NPs electropo-
rated Hep-2 cells showed numerous apoptotic bodies, 
irregular cell membrane of neoplastic and necrotic 
cells with mixed euchromatin and heterochromatin 
(Fig. 4B). Also, Hep-2 cells showed numerous apop-
totic bodies on post short term exposure to ELFEMF 
for 15 min at 25 mT and neoplastic cells with nuclear 
fragmentation and apoptotic body on post longer-
term cell exposure (Fig. 4C); 30 min at 25 mT (Fig. 
4D). Moreover, higher frequency at 50 mT for 15 min 
(Fig. 4E), exposed cells showed numerous apoptotic 
bodies and irregular neoplastic cell membrane and 
clear necrosis with mixed euchromatin and hetero-
chromatin ruptured cell membrane of necrotic cells 
on post cell exposure to 50 mT for 30 min (Fig. 4F).
Discussion 
The present work aimed to use ELFEMF and elec-
troporation with Au-NPs as alternative ways of pro-
motion apoptosis of human laryngeal cancer cells. 
Also, we aimed to preview the genetic and cell cycle 
alterations in Hep-2 cells. The obtained data revealed 
that both electroporation in a presence of Au-NPs and 
cell exposure to ELFEMF could manage the death of 
cancer cells via apoptosis induction. 
The present study indicated that intermittent ex-
posure of laryngeal carcinoma cells (Hep-2) to a 25 
and 50 mT of ELFEMF affected cell cycle profile and 
proved these via noticed elevated up and down-reg-
ulation of apoptosis-related genes. Thus, we showed 
that apoptotic profile and G2/M cellular arrest may 
play the crucial role in the biological effects of 25 
and 50 mT ELFEMF and related induction of DNA 
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Figure 2. Expression analysis of the CASP3, P53, BAX and BCL2 genes in Hep-2 cells at the mRNA level. Gene expression 
was assessed as described in the Materials and methods. (A–D) plots for CASP3, P53, BAX and BCL2 genes’ expression 
ratios in cells after treatment with different conditions, respectively. Bars and whiskers represent mean ± standard deviation 
normalized to control samples. *P < 0.05, **P < 0.01, ***P < 0.001; capped lines: t-test between subgroups; dotted line: 
one-way ANOVA between all subgroups; dashed line: t-test between control and tested cells, respectively. CASP3, caspase 3 
gene; P53, tumor protein 53 gene; BAX, BCL2 associated X; BCL2, B-cell lymphoma 2 gene; DC Au-NPs, direct contact gold 
nanoparticles; EP Au-NPs, electroporation with gold nanoparticles; ELFEMF, extremely-low frequency electromagnetic field.
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Figure 4. Microphotographs of Hep-2 cells after Au-NPs or ELFEMF treatment. A. Control, untreated Hep-2 cells present 
regular tumor cells (yellow arrow), cellular pleomorphism (green arrow) and nuclear pleomorphism (red arrow). B. Hep-2 
Au-NPs electroporated cells show numerous apoptotic bodies (yellow arrows), irregular cell membrane of neoplastic cell 
(green arrow), necrotic cells with euchromatin and heterochromatin (red arrows) and ruptured cell membrane of necrotic 
cells (black arrows). C. Hep-2 cells showing numerous apoptotic bodies post short term exposure to ELFEMF for 15 min at 
25 mT (yellow arrows). D. Hep-2 cells showing neoplastic cells with nuclear fragmentation (yellow arrows) and apoptotic bodies 
(green arrow) post cell exposure for 30 min at 25 mT. E. Hep-2 cells showing numerous apoptotic bodies (yellow arrows) 
after cell exposure to 50 mT for 15 min. F. Hep-2 cells showing numerous apoptotic bodies and irregular cell membrane of 
neoplastic cells (green arrow), necrotic cells (red arrows) and ruptured cell membrane of necrotic cells (black arrows) after 
cell exposure to 50 mT for 30 min. H&E staining, magnification ×40.
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Figure 3. Evaluation of cell cycle of Hep-2 cells using flow cytometry. (A–D) G0/G1, S, G2/M phases and apoptotic cells’ 
proportions of Hep-2 cells. *P < 0.05, **P < 0.01, ***P < 0.001; capped lines: t-test between subgroups; dotted line: one-
way ANOVA between all subgroups; dashed line: t-test between control and tested cells, respectively. DC Au-NPs, direct 
contact gold nanoparticles; EP Au-NPs, electroporation with gold nanoparticles; ELFEMF, extremely-low frequency elec-
tromagnetic field.
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strand breaks. On the other hand, it was observed 
that subjecting cells continuously to a constant elec-
tromagnetic field may induce adaptive mechanisms, 
protecting the genome from harmful influences [14]. 
The point of view concerning this way and effect was 
based on the continuous exposure of people to such 
frequencies via different magnetic field sources such 
as radio and microwave in their homes. The potential 
of ELFEMF to exert harmful biological effects on 
human health is of increasing concern. It has been 
reported that DNA damage may be involved in cell 
proliferation, apoptosis as well as cell cycle [15, 16]. 
The presence of Au-NPs inside the cells allowed 
the introduction and progress of cell damage, especial-
ly cancerous cells. On the other hand, it has been no-
ticed that the cells that were exposed to the ELFEMF 
have developed a high rate of cellular damage. This 
cellular damage was developed by the irreversible 
induction of pores in the cell membrane due to the 
overlapping between the externally applied ELFEMF 
and the magnetic properties of the cell membranes. 
In addition to the effectiveness of the magnetic field 
on the cancerous cells, Au-NPs activate the signaling 
pathways through acting on the membrane proteins 
that leads to the inhibition of the cancer cells prolif-
eration. It was previously observed that the gold na-
noparticles have the ability to enter the cells through 
the endocytosis, which produces mitochondrial 
dysfunction, formation of reactive free radicals and 
the destruction of nucleic acid and cellular proteins 
[17]. Hence, all the used effects allow the inhibition 
of cellular proliferation. Therefore, the utilizing of 
gold nanoparticles in the presence of electroporation 
and the effect of extremely-low electromagnetic field 
has shown remarkable effects. This was done by the 
activation of Au-NPs to start entering the tumor cells, 
especially through electroporation physics enhancers 
accordingly displaying a remarkable ability to treat the 
tumor cells. It was observed that the use of electro-
poration in the presence of gold nanoparticles can be 
effective to induce apoptosis in the Hep-2 cells. More-
over, the combination of electroporation and Au-NPs 
had moderate effect on the studied neoplastic cells. 
Hence, the effect on pro-apoptotic genes (P53 and 
BAX) and anti-apoptotic genes (BCL2) was viewed 
to be significant in the presence of combined action 
of gold nanoparticles and electroporation and the 
ELFEMF treatment with 50 mT and 100 mT. 
The influence of size, shape, and surface modifi-
cation on cytotoxicity of gold nanoparticles to human 
Hep-2 and canine MDCK cells was investigated by 
Zhang et al. [11]. Au-NPs cell treatment revealed that 
cell death induced predominately within one hour 
through apoptosis induced gene expression, whereas 
cell death by free cetyltrimethylammonium-bromide 
(CTAB) was a time- and dose-dependent. Both posi-
tively and negatively surface-charged polymer-coated 
gold nanorods GNRs showed similar levels of cyto-
toxicity, suggesting the significance of surface func-
tionality rather than surface charge in this case [11]. 
As the interaction of gold nanoparticles with cells 
relies on properties of nanoparticles, the cytotoxicity 
is complex and still under debate. In a previously 
published work, they found that cetyltrimethylammo-
nium-bromide (CTAB) encapsulated gold nanorods 
(GNRs) were relatively higher cytotoxic than gold 
nanorods (GNRs) undergone further polymer coating 
and citrate stabilized gold nanospheres (GNSs) [11].
The toxicity of CTAB-encapsulated GNRs was 
mainly caused by CTAB on GNRs’ surface but not 
free CTAB in the solution. On the contrary to our 
data, Brisdelli and coworkers recorded that lower 
frequency ELF-MF (1 mT; 50 Hz) enhanced the ap-
optosis and that ULEMF (25/50 mT; 50 Hz) enhanced 
the apoptosis and cell arrest in human laryngeal car-
cinoma Hep-2 cells [18]. Four different compounds, 
namely vinblastine, etoposide, quercetin, and resver-
atrol, enhanced apoptosis in human K562 chronic 
myeloid leukemia cells. The exposure to ELFEMF 
did not affect growth and viability of untreated K562 
cells and did not influence the anti-proliferative ef-
fects of resveratrol, vinblastine, and etoposide [18]. 
On the contrary, in quercetin treated cells, exposure 
to ELFEMF significantly reduced the percentage of 
apoptotic cells and the caspase-3 activity and modi-
fied the cell cycle profile especially after 48 hours of 
exposure. In addition, the simultaneous treatments for 
24 hours with quercetin plus ELFEMF increased 
Bcl-2 protein expression and prevented quercetin-in-
duced downregulation of Mcl-1 and Bcl-xL [18].
The ELFMF-dependent modulation of the expres-
sion of anti-apoptotic Bcl-2 family and Hsp70 proteins 
could act as a pro-survival mechanism in K562 cells 
[18]. ELFEMF seems to produce several biological 
effects such as changes in cell proliferation, cell dif-
ferentiation, cell cycle and enzyme activity [19–22]. 
Moreover, ELFEMF was found to affect cellular 
redox homeostasis, modulation of physiological func-
tions such as mitochondrial membrane potential, Ca+2 
signaling and homeostasis, and ATP synthesis [23–25]. 
Alterations in the apoptosis process are involved in 
the pathogenesis of many types of cancer [26]. There 
is evidence implicating ELFEMF in the development 
of this disease in humans [27], and many in vitro stud-
ies have also reported correlation between apoptotic 
process and ELFEMF. The latter has been involved 
in the reduction or delay of cell apoptosis process, as 
well as in its stimulation [28, 29]. 
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Additionally, some studies reported evidence sug-
gesting the combined effects of ELFEMF and various 
chemicals and physical agents in modulating the ap-
optotic cascade [30, 31]. However, current research is 
characterized by conflicting data, and synergistic and/ 
/or antagonistic effect induced by ELFEMF has been 
described in H2O2-treated erythroleukemia cell line 
[32]. Also, our data was on the contrary of the previous 
work recording that the effects of 50 Hz ELFEMF 
exposure on the growth of GC-2 and cell viability 
was detected with the CCK-8 kit following 50 Hz 
ELFEMF exposure at different magnetic intensities 
for 72 hours to explore the effects of the ELFEMF 
on the growth of GC-2 cells [33]. Data showed that the 
50 Hz ELFEMF did not markedly affect the morpholo-
gy or viability (CCK-8) of GC-2 cells. Also, the effect of 
50 Hz ELFEMF exposure on the apoptosis and cell cy-
cle of GC-2 cells result showed that 50 Hz (ELFEMF) 
did not induce apoptosis in GC-2 cells compared with 
the same group [33]. Additionally, the percentages 
of G1-, S-, and G2-M phase cells did not significantly 
differ between the exposed groups post-treatment with 
50 Hz ELFEMF for 72 hours. These findings confirmed 
that 50 Hz ELFEMF did not induce apoptosis or cell 
cycle arrest in GC-2 cell [34–36].
Based on the presented data, it could be con-
cluded that the treatment of Hep-2 cancer cell with 
ELFEMF and electroporation with Au-NPs can cause 
cell damage inducing cell cycle arrest and apoptosis. 
Apoptotic and cell cycle profiles were cell type, time 
and ELFEMF frequency dependent. Usage of either 
Au-NPs-electroporation or ELFEMF in anti-cancer 
therapy may be a promising cancer therapy tool, may 
substitute or enhance the radio-, chemotherapy and 
surgical therapy approaches with least adverse effects. 
More intensified trials are recommended on different 
cancer cell lines as well as in vivo studies and different 
formulation of different nanoparticles shapes and 
concentrations must be validated.
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